Weisberg, E., Catley, L., Wright, R. D., Moreno, D., Banerji, L., Ray, A., . . . Griffin, J. D. (2007). Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL(+) leukemias. American Society of Hematology.
Styl ChicagoWeisberg, Ellen, et al. Beneficial Effects of Combining Nilotinib and Imatinib in Preclinical Models of BCR-ABL(+) Leukemias. American Society of Hematology, 2007.
Citace podle MLAWeisberg, Ellen, et al. Beneficial Effects of Combining Nilotinib and Imatinib in Preclinical Models of BCR-ABL(+) Leukemias. American Society of Hematology, 2007.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..